Hydrochloric Acid → HCID 131713431, compound
Reaction equation
C[N+](C)=CCl.[Cl-].P(Cl)(Cl)(Cl)=O.[CH:12]([NH:14][C:15]1[S:16][C:17]([Cl:34])=[C:18]([C:20](=[N:24][O:25][CH2:26][C:27]([O:29][C:30]([CH3:33])([CH3:32])[CH3:31])=[O:28])[C:21]([OH:23])=O)[N:19]=1)=[O:13].[NH2:35][CH:36]1[C:46](=[O:47])[N:38]2[C:39]([C:43]([OH:45])=[O:44])=[CH:40][CH2:41][S:42][C@H:37]12.C[Si](C)(C)NC(=O)C.C(=O)(O)[O-].[Na+].Cl>O1CCCC1.C(Cl)Cl.C(OCC)(=O)C.O.CN(C)C=O>[CH:12]([NH:14][C:15]1[S:16][C:17]([Cl:34])=[C:18]([C:20](=[N:24][O:25][CH2:26][C:27]([O:29][C:30]([CH3:33])([CH3:32])[CH3:31])=[O:28])[C:21]([NH:35][CH:36]2[C:46](=[O:47])[N:38]3[C:39]([C:43]([OH:45])=[O:44])=[CH:40][CH2:41][S:42][C@H:37]23)=[O:23])[N:19]=1)=[O:13]Participants
Reactant 7
Product 1
Reagents, catalysts & solvents 5
Procedure
Vilsmeier reagent prepared from N,N-dimethylformamide (0.46 ml) and phosphorous oxychloride (0.55 ml) was suspended in dry tetrahydrofuran (20 ml). To the suspension was added 2-(2-formamido-5-chlorothiazol-4-yl)-2-tert-butoxycarbonylmethoxyiminoacetic acid (syn isomer) (1.8 g) under ice-cooling with stirring and then the solution was stirred at the same temperature for an hour to prepare the activated acid solution. To the solution of 7-amino-3-cephem-4-carboxylic acid (1.1 g) and N-trimethylsilylacetamide (6.5 g) in methylene chloride (20 ml) was added the activated acid solution obtained above all at once at -20° C., and the solution was stirred at -20° C. to -10° C. for an hour. After water and ethyl acetate were added to the resultant solution, the mixed solution was adjusted to pH 7.3 with a saturated aqueous solution of sodium bicarbonate. Then the aqueous layer was adjusted to pH 2.0 with conc. hydrochloric acid, extracted with mixed solvent of ethyl acetate (100 ml) and tetrahydrofuran (50 ml). The organic layer was washed with a saturated aqueous solution of sodium chloride and dried over magnesium sulfate. After removing the solvent, diisopropyl ether was added to the residue. The insoluble residue was collected by filtration to give 7-[2-(2-formamido-5-chlorothiazol-4-yl)-2-tert-butoxycarbonylmethoxyiminoacetamido]-3-cephem-4-carboxylic acid (syn isomer) (2.35 g), mp 145° to 149° C. (dec.).
Workup
- temperaturecooling
- stirringthe solution was stirred at the same temperature for an hour
- customto prepare the activated acid solution
- customobtained above all at once at -20° C.
- stirringthe solution was stirred at -20° C. to -10° C. for an hour
- extractionextracted with mixed solvent of ethyl acetate (100 ml) and tetrahydrofuran (50 ml)
- washThe organic layer was washed with a saturated aqueous solution of sodium chloride
- dry with materialdried over magnesium sulfate
- customAfter removing the solvent, diisopropyl ether
- additionwas added to the residue
- filtrationThe insoluble residue was collected by filtration
Sources & evidence
- ORD record
- ord-236c8cb2f5324971b40c34ed27e557fd
- Source dataset
- uspto-grants-1986_06
- Patent number
- US04596829
Reaction notes
Loading…